TrialJournal of psychopharmacology (Oxford, England)2022

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

Natalie Gukasyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.